Myxedema coma: Difference between revisions

No edit summary
No edit summary
Line 8: Line 8:


===Precipitants===
===Precipitants===
#[[Sepsis]]
*Bradycardia and hypothermia
#Bradycardia and hypothermia
*Burns
#Cold exposure
*[[CHF]]
#Trauma
*[[CVA]]
#[[MI]]
*Cold exposure
#[[CHF]]
*[[GI bleed]]
#[[CVA]]
*Metabolic abnormalities ([[hypoxia]], [[hypercapnia]], [[hyponatremia]], [[hypoglycemia]])
#[[GI bleed]]
*Medications: B-blockers, sedatives, narcotics, phenothiazine, amiodarone<ref>Mazonson PD et al. Myxedema coma during long-term amiodarone therapy. Am J Med. 1984;77:751–4.</ref>
#Metabolic conditions ([[hypoxia]], [[hypercapnia]], [[hyponatremia]], [[hypoglycemia]])
*Medication non-compliance (thyroid meds)
#Burns
*[[MI]]
#Meds: B-blockers, sedatives, narcotics, phenothiazine, amiodarone<ref>Mazonson PD et al. Myxedema coma during long-term amiodarone therapy. Am J Med. 1984;77:751–4.</ref>
*[[Sepsis]]
#Medication non-compliance (thyroid meds)
*Trauma


==Clinical Features==
==Clinical Features==
Line 38: Line 38:


==Differential Diagnosis==
==Differential Diagnosis==
*[[Sepsis]]
*[[Depression]]
*[[Adrenal crisis]]
*[[Adrenal crisis]]
*[[CHF]]
*[[CHF]]
*[[CVA]]
*[[Depression]]
*[[Drug overdose]]
*[[Hypoglycemia]]
*[[Hypoglycemia]]
*[[CVA]]
*[[Hypothermia]]
*[[Hypothermia]]
*[[Drug overdose]]
*[[Meningitis]]
*[[Meningitis]]
*[[Sepsis]]


==Diagnosis==
==Diagnosis==
===Work-Up===
===Work-Up===
#Chemistry
*Chemistry
#CBC
*CBC
#TSH, FT4, FT3
*TSH, FT4, FT3
#Cultures  
*Cultures  
#LFT
*LFT
#Cortisol level  
*Cortisol level  
#VBG
*VBG
#CXR  
*CXR  
#EKG  
*EKG  


===Lab Abnormalities===
===Lab Abnormalities===

Revision as of 03:28, 11 August 2015

Background

  • Hypothyroidism + mental status changes/coma + hypothermia + precipitating stressor[1]
  • Majority of the patients will be > 60yo[2]
  • Occurs in 0.1% of patients with hypothyroidism
  • Mortality may be as high as 60%[3]
  • Coma does not need to be present but there will be a decline in the patient's mental status. Sever hypothyroidism may present with severe decompensated hypothyroidism as the first presentation of undiagnosed hypothyroidism[4]
  • The classic myxedematous face, which is characterized by generalized puffiness, macroglossia, ptosis, periorbital edema may not be present, but other signs such as a palpaple goiter and thyroid medication use will help in suspecting the diagnosis.

Precipitants

Clinical Features

Hypothermia

  • Temperature <35.5°C (95.9°F).

Cardiovascular

Pulmonary

  • Hypoventilation
    • Early respiratory support with intubation is necessary to prevent respiratory collapse
  • Hypercapnia
    • There is often diaphragmatic dysfunction that causes worsening hypoventilation. The dysfunction is reversed after thryroid hormone administration[6]
  • Pleural Effusion
  • Upper airway obstruction from glottic edema, vocal cord edema, and macroglossia can complicate intubation.

Neurologic

Differential Diagnosis

Diagnosis

Work-Up

  • Chemistry
  • CBC
  • TSH, FT4, FT3
  • Cultures
  • LFT
  • Cortisol level
  • VBG
  • CXR
  • EKG

Lab Abnormalities

Management

Respiratory Support

  • Early mechanical ventilation will prevent resipatory collapse and severe respiratory acidosis.

Fluid Resuscitation

  • Patients are often intravsascularly depleted and have an underlying infection mandating agressive fluid resususcitation
  • In patients who are hyponatremia, be cautious with rapid correction of hyponatremia and choose an appropriate fluid
  • Hypoglycemic patients will require intravenous dextrose added into the fluids

Hypotension

  • Vasopressors will be ineffective without concomitant thyroid hormone replacement

Hormone Replacment

  • Hydrocortisone 100mg q8hr IV since there is also adrenal insufficiency present
  • Levothyroxine (T4) (generally agreed upon first line therapy)
    • Dose: 100 to 500 mcg (4mcg/kg IV) followed by 75 to 100 mcg administered IV daily until the patient takes oral replacement.[7]
    • Does require extrathyroidal conversion which can be reduced in myxedema but will have a slow steady onset of action and potentially safer in patients with coronary artery disease (CAD).
  • T3
  • Dose: 20mcg IV followed by 10mcg q8hr (Start with 10mcg if elderly or has CAD)
  • Does not require extrathyroidal conversion and has more rapid onset but may be harmful in patients with severe coronary artery disease.

Hypothermia

  • Treat with passive rewarming
  • Hypothermia will also reverse with thryoid hormone administration

Disposition

  • Admit to ICU

See Also

References

  1. Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician. Dec 1 2000;62(11):2485-90.
  2. Davis PJ, Davis FB. Hypothyroidism in the elderly. Compr Ther. 1984;10:17–23.
  3. Arlot S et al. Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment. Intensive Care Med. 1991;17:16–8.
  4. Nicoloff JT et al. A form of decompensated hypothyroidism. Endocrinol Metab Clin North Am. 1993;22:279–90.
  5. Mazonson PD et al. Myxedema coma during long-term amiodarone therapy. Am J Med. 1984;77:751–4.
  6. Martinez FJ et al. Hypothyroidism. A reversible cause of diaphragmatic dysfunction. Chest. 1989;96:1059–63.
  7. Smallridge RC. Metabolic and anatomic thyroid emergencies: a review. Crit Care Med. 1992;20:276–91